A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

Update Il y a 4 ans
Reference: NCT00859807

Woman and Man

  • | Country :
  • India
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).


Inclusion criteria

  • Falciparum malaria

Links